Novartis AG (VIE:NOVN)

Austria flag Austria · Delayed Price · Currency is EUR
115.00
+0.40 (0.35%)
At close: Dec 5, 2025
Market Cap 219.33B
Revenue (ttm) 48.05B
Net Income (ttm) 12.27B
Shares Out n/a
EPS (ttm) 6.22
PE Ratio 17.88
Forward PE 15.35
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 5
Open 114.88
Previous Close 114.60
Day's Range 114.88 - 115.08
52-Week Range 94.21 - 115.86
Beta n/a
RSI 63.79
Earnings Date Feb 4, 2026

About Novartis AG

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Revolade to treat immune thrombocy... [Read more]

Industry Pharmaceutical Preparations
Founded 1996
Employees 75,883
Stock Exchange Vienna Stock Exchange
Ticker Symbol NOVN
Full Company Profile

Financial Performance

In 2024, Novartis AG's revenue was $51.72 billion, an increase of 10.85% compared to the previous year's $46.66 billion. Earnings were $11.94 billion, a decrease of -19.59%.

Financial numbers in USD Financial Statements

News

There is no news available yet.